Fasting Cancer
How Fasting and Nutritechnology Are Creating a Revolution in Cancer Prevention and Treatment
Sinopsis
Despite all our scientific advances, which have allowed us to prevent and treat so many deadly diseases, almost one in two people will develop cancer in the U.S. In Fasting Cancer, Dr. Valter Longo, one of the leading scientists in the field of nutrition and cancer, reveals the results of decades of research on the fasting and nutrition technology−based studies to defeat cancer in the body, making only tumor cells much more vulnerable to therapy while protecting the healthy cells.
Fasting Cancer creates a new path in which the patient is an active codriver of the therapy by turning on the body’s ability to fight cancer. Dr. Longo’s studies show that the fasting-mimicking diet is beginning to make cancer therapies potentially more effective and less toxic to patients, thus providing an evidence-based complementary approach to mainstream treatments. The book also describes how the everyday Longevity Diet and plant-based ketogenic diet can support cancer therapies.
Rich in patient stories and clinical data, Fasting Cancer is a read that invites everyone—doctors, healthcare professionals, patients, and family members—to understand the extraordinary potential of a new approach to help fight cancer.
-15€ en eReader Vivlio Light Zen*
Este verano lee sin parar. Del 13 de julio al 2 de agosto llévate nuestro eReader Vivlio Light Zen por solo 94,99€ (-15 € de descuento).
Léelo en cualquier dispositivo
Ficha Técnica
Editorial: Avery
ISBN: 9780593545331
Idioma: Inglés
Fecha de lanzamiento: 04/02/2025
Especificaciones del producto
Recibe novedades de Valter Longo directamente en tu email
Reseñas sobre Fasting Cancer
Comparte tu experiencia con la comunidad lectora.
0 Reseñas
Sólo por opinar entras en el sorteo mensual de tres tarjetas regalo valoradas en
20€
*Descuento de 15 euros en el eReader Vivlio Light Zen, válido para pedidos realizados en casadellibro.com del 13 de julio al 2 de agosto y solo para los 300 primeros compradores, hasta fin de existencias.